Figure 6.
Figure 6. CD4+ and CD8+ T-cell PD-1 expression in CML patients at diagnosis, pre-MMR, MMR, MR4.5, TFR, and in HD. (A) CD3+/CD4+/CD8+ T-cell gating to assess PD-1 expression. CD4+ and CD8+ T-cell PD-1+ expression is shown as a percentage of total lymphocytes. (B) Representative patient (of 8 patient samples) showing the absolute number of CD4+PD-1+ (blue) and CD8+PD-1+ (green) T cells per microliter against BCR-ABL1 (red) over time. Bars denote the median. ***P ≤ .001; **P ≤ .01; *P ≤ .05.

CD4+and CD8+T-cell PD-1 expression in CML patients at diagnosis, pre-MMR, MMR, MR4.5, TFR, and in HD. (A) CD3+/CD4+/CD8+ T-cell gating to assess PD-1 expression. CD4+ and CD8+ T-cell PD-1+ expression is shown as a percentage of total lymphocytes. (B) Representative patient (of 8 patient samples) showing the absolute number of CD4+PD-1+ (blue) and CD8+PD-1+ (green) T cells per microliter against BCR-ABL1 (red) over time. Bars denote the median. ***P ≤ .001; **P ≤ .01; *P ≤ .05.

Close Modal

or Create an Account

Close Modal
Close Modal